IHC staining assays were used to detect PRMT2 with an anti-PRMT2 antibody on tissue microarray (TMA) slides, which contained 68 normal kidney tissues and 306 RCC patient tissues. This evidence concerns the gene PRMT2 and renal cell adenocarcinoma.